The demand for public healthcare in emerging markets has steadily increased as developing countries transition from poverty-related diseases to chronic, age-related diseases commonplace in more mature markets.
As growth trends in mature markets plateau due to the patent-cliff, rising R&D costs, and more complex, riskier research, global pharmaceutical companies are developing in these areas to explore new sources of profitability in emerging markets.
Government organizations face several challenges around talent development and retention in emerging markets that are compounded by regional and industry-specific talent management complexities. Some of the biggest obstacles:
The following steps offer a methodical and strategic way for public sector organizations to develop their talent strategy: